Groeninge Hospital
- Address
- President Kennedylaan 5, Kortrijk, Belgium
Groeninge Hospital - Cardiovascular and Neurovascular Research
Groeninge Hospital is actively engaged in cutting-edge cardiovascular research, with particular expertise in managing complex cases involving both cardiac arrhythmias and cerebrovascular complications. The center demonstrates specialized capabilities in studying high-risk patient populations where traditional treatment approaches require careful reconsideration.
- Atrial fibrillation management in high-risk populations
- Anticoagulation therapy optimization following intracranial hemorrhage
- Stroke prevention strategies in complex cardiovascular patients
The hospital's research portfolio focuses on the critical challenge of preventing ischemic stroke while minimizing bleeding risks in patients with atrial fibrillation who have survived intracranial hemorrhage. This work addresses a significant clinical dilemma where the need for anticoagulation to prevent thromboembolism must be carefully balanced against the elevated risk of recurrent bleeding events in vulnerable patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Groeninge Hospital
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Colchicine for Reducing Dependency and MACE in Acute Intracerebral Hemorrhage Survivors with Atherosclerotic Risk: Randomized Placebo-Controlled Trial | Hamilton Health Sciences Corporation, PHRI Population Health Research Institute International | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Colchicine | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.